Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06438666
Other study ID # tDCS_2024UMA
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 20, 2025
Est. completion date March 20, 2027

Study information

Verified date May 2024
Source University of Malaga
Contact Rocío Martín Valero, PhD
Phone 951952858
Email rovalemas@uma.es
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Spastic Hemiparetic Cerebral Palsy (SHCP) uses to limit the manual function. Using anodic transcranial direct current stimulation, it is possible to activate certain cerebral areas depending on where the electrodes are. This study will use this kind of stimulation on the contralateral primary motor cortex of the affected upper limb and analyze the effects.


Description:

It has been designed a single-arm prospective longitudinal quasi-experimental pilot clinical study following the SPIRIT 2013 statement. It will value the time that the children spend doing the bimanual activities described by the Children's Hand-Use Experience Questionnaire (CHEQ), it will also value the subjective experience doing those activities; it will analyze the active movement (Fugl-Meyer for upper limb), spasticity (modified Ashworth), manual strength (dynamometry) and the recruitment improvement (surface electromyography) too. This study will apply the anodic transcranial direct current stimulation over 20 children between 14-18 years old. The protocol that it will follow is the next one: 3 days to value the outcome measures, 4 days (1 session per day of 17 minutes and 30 seconds) to apply the protocol of anodic transcranial direct current stimulation (0,6 mA of intensity). It will use the EPTE V07 Bipolar System by IONCLINICS ®; 3 days to value the outcome measures studying the effects produced at the affected upper limb. Another evaluation will be realized 3 weeks after the last session of anodic transcranial direct current stimulation to know if the effects obtained last at medium-long term.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date March 20, 2027
Est. primary completion date December 23, 2026
Accepts healthy volunteers No
Gender All
Age group 14 Years to 18 Years
Eligibility Inclusion Criteria: - Children between 14-18 years old. - Children with spastic hemiparetic cerebral palsy diagnosis. - Children with a cognitive level high enough to understand and to do the activities to value them. - Children hemodynamically stable. - Children forming part of levels II-IV of the Manual Ability Classification System (MACS). Exclusion Criteria: - Children with defibrillator. - Children with pacemaker. - Children with cerebral stimulator. - Children with intracranial metallic implants. - Children with opened cranial after clambering. - Children that receive another treatment (pharmacological or physiotherapical) that could interfere or disrupt the results. - Another circumstance where the electrotherapy treatment is contraindicated.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Anodic Transcranial Direct Current Stimulation
This study will apply the anodic transcranial direct current stimulation over 20 children between 14-18 years old. The protocol that it will follow is the next one: 3 days to value the outcome measures, 4 days (1 sessions per day of 17 minutes and 30 seconds) to apply the protocol of anodic transcranial direct current stimulation (0,6 mA of intensity). It will use the EPTE V07 Bipolar System by IONCLINICS ®; 3 days to value the outcome measures studying the effects produced at the affected upper limb. Another evaluation will be realized 3 weeks after the last sessions of anodic transcranial direct current stimulation to know if the effects obtained last at medium-long term.

Locations

Country Name City State
Spain Rocío Martín Valero Málaga

Sponsors (2)

Lead Sponsor Collaborator
University of Malaga Jorge Manuel Góngora Rodríguez

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in the timing that children use to complete the 29 items of the Children's Hand-Use Experience Questionnaire (CHEQ). CHEQ is a questionnaire analyze the time it takes the children (between 6-18 years old) to do 29 functional activities; it also values the subjective experience of the children doing theses activities. It has a punctuation that goes from 1 to 4 (the maximum score is 348). If the score is higher, it means that the children's status is better. Baseline, after 4 days (after de foruth sessions planned) and 3 weeks later
Secondary Changes at the spasticity Ashworth modified scale is a scale that values the spasticity. It has a punctuation that goes from 0 to 4. If the score is higher, it means that the spasticity is worse. Baseline, after 4 days (after the fourth sessions planned) and 3 weeks later
Secondary Changes at the active movement Fugl-Meyer scale for upper limb Is a scale that values the active movement, the sensibility, joints pain and passive movement of the upper limb. It has a punctuation that goes from 0 to 2 (the maximun score is 126). If the score is higher, it means that all it values are fine. Baseline, after 4 days (after the fourth sessions planned) and 3 weeks later
Secondary Changes at the manual strength Dynamometry is a test that values the hand strength. Baseline, after 4 days (after the fourth sessions planned) and 3 weeks later
Secondary Changes at the recruitment of the motor units. Surface electromyography is a test that values the improvement in the recruitment of the motor units. Baseline, after 4 days (after the fourth sessions planned) and 3 weeks later
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05349136 - Telerehabilitation-Based Action Observation Treatment in Children With Hemiparetic Cerebral Palsy N/A
Completed NCT00991692 - A Multisite Trial of ACQUIREc Therapy N/A
Not yet recruiting NCT03792789 - Evaluation of Repetitive Transcranial Magnetic Stimulation as an Adjunct to Modified Constraint Induced Movement Therapy in Improving Upper Limb Function in Children With Hemiparetic Cerebral Palsy Aged 5 - 18 Years N/A